These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 12187169)
21. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Du XL; Key CR; Dickie L; Darling R; Geraci JM; Zhang D Med Care; 2006 Feb; 44(2):124-31. PubMed ID: 16434911 [TBL] [Abstract][Full Text] [Related]
22. Measuring breast, colorectal, and prostate cancer screening with medicare claims data. Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166 [TBL] [Abstract][Full Text] [Related]
23. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184 [TBL] [Abstract][Full Text] [Related]
24. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry. Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070 [TBL] [Abstract][Full Text] [Related]
25. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. Du X; Goodwin JS J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491 [TBL] [Abstract][Full Text] [Related]
26. Completeness of American Cancer Registry Treatment Data: implications for quality of care research. Mallin K; Palis BE; Watroba N; Stewart AK; Walczak D; Singer J; Barron J; Blumenthal W; Haydu G; Edge SB J Am Coll Surg; 2013 Mar; 216(3):428-37. PubMed ID: 23357724 [TBL] [Abstract][Full Text] [Related]
27. Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data. Gore JL; Wright P; Shih V; Chang NN; Noshad S; Rey GG; Wang S; Narayanan S JCO Clin Cancer Inform; 2024 Sep; 8():e2400073. PubMed ID: 39298694 [TBL] [Abstract][Full Text] [Related]
28. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010 [TBL] [Abstract][Full Text] [Related]
29. Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Schrag D; Bach PB; Dahlman C; Warren JL Med Care; 2002 Aug; 40(8 Suppl):IV-96-103. PubMed ID: 12187174 [TBL] [Abstract][Full Text] [Related]
30. External validation of a claims-based algorithm for classifying kidney-cancer surgeries. Miller DC; Saigal CS; Warren JL; Leventhal M; Deapen D; Banerjee M; Lai J; Hanley J; Litwin MS BMC Health Serv Res; 2009 Jun; 9():92. PubMed ID: 19500395 [TBL] [Abstract][Full Text] [Related]
31. Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer. Bronson MR; Kapadia NS; Austin AM; Wang Q; Feskanich D; Bynum JPW; Grodstein F; Tosteson ANA Med Care; 2018 Dec; 56(12):e83-e89. PubMed ID: 29334524 [TBL] [Abstract][Full Text] [Related]
32. Use of Medicare hospital and physician data to assess breast cancer incidence. Warren JL; Feuer E; Potosky AL; Riley GF; Lynch CF Med Care; 1999 May; 37(5):445-56. PubMed ID: 10335747 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans. Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555 [TBL] [Abstract][Full Text] [Related]
34. Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review. Fleming ST; Hamilton AS; Sabatino SA; Kimmick GG; Wu XC; Owen JB; Huang B; Hwang W; Med Care; 2014 Sep; 52(9):e58-64. PubMed ID: 23222532 [TBL] [Abstract][Full Text] [Related]
35. Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis. Vogel TJ; Jeon C; Karlan B; Walsh C Gynecol Oncol; 2016 Feb; 140(2):285-8. PubMed ID: 26691221 [TBL] [Abstract][Full Text] [Related]
36. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Klabunde CN; Harlan LC; Warren JL Med Care; 2006 Oct; 44(10):921-8. PubMed ID: 17001263 [TBL] [Abstract][Full Text] [Related]
37. Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Baldwin LM; Adamache W; Klabunde CN; Kenward K; Dahlman C; L Warren J Med Care; 2002 Aug; 40(8 Suppl):IV-82-95. PubMed ID: 12187173 [TBL] [Abstract][Full Text] [Related]
38. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306 [TBL] [Abstract][Full Text] [Related]
39. Identifying Cancer-Directed Surgeries in Medicare Claims: A Validation Study Using SEER-Medicare Data. Lavery JA; Lipitz-Snyderman A; Li DG; Bach PB; Panageas KS JCO Clin Cancer Inform; 2019 Feb; 3():1-24. PubMed ID: 30715928 [TBL] [Abstract][Full Text] [Related]
40. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries. Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]